EU Committee Gets Tough On Environmental Pharma Pollution
Better Controls, Lower Drug Consumption Advised
Members of the European Parliament have backed tougher measures to tackle the damage caused to the environment by pharmaceuticals, saying the approach outlined by the European Commission last year is too “soft.”
You may also be interested in...
The European Commission has outlined actions that the pharmaceutical industry and other stakeholders need to take in order to minimize the risk of pharmaceuticals contaminating the environment.
The pharmaceutical industry has given a muted welcome to proposals for building up the EU's resilience to medicine shortages, saying many of the ideas will not tackle the root causes of supply problems and could even serve to undermine innovation.
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.